Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
26%
OVERLAP
BY WEIGHT
12
# OF OVERLAPPING
HOLDINGS
IDNA
44
HOLDINGS
32%
ALSO IN CANC
CANC
53
HOLDINGS
23%
ALSO IN IDNA
SECTOR DRIFT (IDNA minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IDNA |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
REVOLUTION MEDICINES, INC. | 6.4% | 6.3% | 6.3% |
 |
ASTRAZENECA PLC | 4.1% | 4.3% | 4.1% |
|
EXELIXIS INC | 3.2% | 3.1% | 3.1% |
|
MERCK & CO. INC. | 4.3% | 2.7% | 2.7% |
|
CELCUITY INC. | 6.2% | 2.5% | 2.5% |
IDNA Overweight Relative to CANC
 |
GENMAB A/S | 4.8% |
|
INCYTE CORP | 4.7% |
 |
ROCHE HOLDING LTD | 4.1% |
|
REGENERON PHARMACEUTICALS | 4.0% |
|
GSK PLC | 4.0% |
|
CELCUITY INC. | 3.6% |
|
MODERNA, INC. | 3.6% |
|
TWIST BIOSCIENCE CORP. | 3.3% |
 |
SANOFI-AVENTIS | 3.3% |
 |
TAKEDA PHARMACEUTICAL CO LTD | 3.2% |
IDNA Underweight Relative to CANC
|
ELI LILLY & CO | -5.1% |
|
BRIDGEBIO PHARMA, INC. | -4.4% |
|
NOVARTIS AG | -4.1% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -3.9% |
|
COGENT BIOSCIENCES INC | -3.9% |
|
GENMAB A/S SPONSORED ADR | -3.8% |
|
BRISTOL-MYERS SQUIBB CO | -3.4% |
|
NUVALENT, INC. CLASS A | -3.3% |
|
JOHNSON & JOHNSON | -3.2% |
|
ABBVIE INC | -2.8% |